F8 and hemophilia: Given the very significant negative influence of inhibitor development on hemophilia care, the potential intervention with gene therapy is a reasonable consideration, and, indeed, in the dog model of hemophilia A, there is objective evidence that FVIII tolerance can be achieved through AAV-mediated gene transfer to the liver.65